mRNA |
QL-XII-47 |
GDSC1000 |
pan-cancer |
AAC |
-0.087 |
0.02 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.02 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.03 |
mRNA |
Repligen 136 |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.03 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.03 |
mRNA |
Bexarotene |
GDSC1000 |
pan-cancer |
AAC |
-0.093 |
0.03 |
mRNA |
IOX2 |
GDSC1000 |
pan-cancer |
AAC |
0.088 |
0.03 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.03 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.03 |
mRNA |
cediranib |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.03 |